Real-time continuous glucose monitoring is seeing a real-world trial after the FDA stated it would not object to its use during the COVID-19 pandemic
ACP Internist Weekly
New vaccine authorization and data, NIH on antibody treatment and ‘long COVID’
Study finds no difference in muscle symptom scores between statin, placebo
For too many clinicians, racism is a defining component of work culture. Health care organizations should adopt antiracist practices that result in sustained, meaningful change.
This column reviews details on recent recalls, warnings, and approvals.
President Biden wants to shake up health care policy in a direction that ACP has long called for on many issues. Congress will have a big say in whether grander and bigger changes occur.
A 30-year-old man is evaluated for a 1-week history of sore throat and odynophagia. He reports no fever, nausea, vomiting, diarrhea, or other symptoms. He was recently diagnosed with HIV infection and began antiretroviral therapy 2 weeks ago. Following a physical exam, oral exam, and lab studies, what is the most appropriate management?
This issue also covers the origins of medical eponyms, continuous glucose monitoring in the hospital, and a preview of ACP's virtual Internal Medicine Meeting.
Latest Blog Posts
Sinking in Bed Syndrome has been made worse by COVID-19
Posted Oct 15 at 1:00 PM
Behind the mask assessing risk in COVID-19: playing risk
Posted Sep 24 at 1:00 PM
Behind the mask: school days
Posted Sep 10 at 1:00 PM